Natural Killer Cells in Multiple Sclerosis: Entering the Stage

Area of Science:

• Immunology
• Neuroscience
• Autoimmune Diseases

Background:

• Multiple sclerosis (MS) research traditionally focused on adaptive immunity (T and B cells).
• Innate immune cells, particularly natural killer (NK) cells, are now gaining attention for their role in MS pathogenesis.
• NK cells modulate adaptive immunity and are implicated in autoimmune diseases.

Purpose of the Study:

• To review current research on the role of NK cells in multiple sclerosis (MS) immunopathology.
• To explore evidence from animal models, genetic studies, and patient-derived immunology.
• To highlight the significance of NK cell heterogeneity in MS.

Main Methods:

• Review of studies using the experimental autoimmune encephalomyelitis (EAE) animal model.
• Analysis of MS genetics and ex vivo/in vitro immunology of MS patients.
• Application of hypothesis-free technologies like single-cell transcriptomics.

Main Results:

• Evidence suggests NK cells contribute to the immunopathology of MS.
• Single-cell transcriptomics reveals significant NK cell heterogeneity.
• The distinction between innate and adaptive immunity is becoming less clear due to NK cell complexity.

Conclusions:

• Unraveling NK cell heterogeneity is crucial for understanding MS.
• Identifying mechanistic links between innate and adaptive immune cells is key.
• NK cells show promise as prognostic tools and therapeutic targets for MS and other autoimmune disorders.